アネキシンV
- 関
- annexin A5、placental anticoagulant protein I
WordNet
- an addition that extends a main building (同)annexe, extension, wing
- take (territory) as if by conquest; "Hitler annexed Lithuania"
- attach to
- the 22nd letter of the Roman alphabet (同)v
PrepTutorEJDIC
- (…に)〈さらに大きな物〉'を'付け加える,添える《+『名』+『to』+『名』》 / (…に)〈領土・会社など〉'を'併合する《+『名』+『to』+『名』》 / 《話》〈他人の物〉'を'失敬する / (…への)付加物;建て増し,(…の)別館《+『to』+『名』》 / (…の)付属文書(書類),付録《+『to』+『名』》
- vanadium の化学記号
- verb / verso / 《話》very / velocity / volt[s] / volume / vide
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2016/09/06 14:11:43」(JST)
[Wiki en表示]
ANXA5 |
|
Available structures |
PDB |
Ortholog search: PDBe RCSB |
List of PDB id codes |
2XO3, 1ANW, 1ANX, 1AVH, 1AVR, 1HAK, 1HVD, 1HVE, 1HVF, 1HVG, 1SAV, 2XO2
|
|
|
Identifiers |
Aliases |
ANXA5, ANX5, ENX2, HEL-S-7, PP4, RPRGL3, annexin A5 |
External IDs |
OMIM: 131230 MGI: 106008 HomoloGene: 20312 GeneCards: 308 |
|
Genetically Related Diseases |
Disease Name |
References |
chronic obstructive pulmonary disease |
|
Gene ontology |
Molecular function |
• phospholipase inhibitor activity
• calcium ion binding
• calcium-transporting ATPase activity
• receptor tyrosine kinase binding
• peptide hormone binding
• protein binding
• calcium-dependent phospholipid binding
• phospholipid binding
|
Cellular component |
• cytoplasm
• axon terminus
• cytosol
• perikaryon
• cell projection
• membrane
• synaptic vesicle
• intercalated disc
• focal adhesion
• plasma membrane
• intracellular
• Q14325730
• endothelial microparticle
• neuronal cell body
• dendrite
• Z disc
• endoplasmic reticulum
• sarcolemma
• extracellular exosome
• external side of plasma membrane
• nucleus
|
Biological process |
• hemostasis
• cellular response to lead ion
• mitophagy in response to mitochondrial depolarization
• regulation of sperm motility
• negative regulation of blood coagulation
• negative regulation of coagulation
• response to thyroid hormone
• blood coagulation
• negative regulation of apoptotic process
• cellular response to gonadotropin-releasing hormone
• response to organic substance
• response to calcium ion
• calcium ion transmembrane transport
• positive regulation of apoptotic process
• negative regulation of prolactin secretion
• protein homooligomerization
• xenophagy
• signal transduction
• positive regulation of defense response to virus by host
• negative regulation of catalytic activity
|
Sources:Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
|
|
Ensembl |
|
|
UniProt |
|
|
RefSeq (mRNA) |
|
|
RefSeq (protein) |
|
|
Location (UCSC) |
Chr 4: 121.67 – 121.7 Mb |
Chr 3: 36.45 – 36.48 Mb |
PubMed search |
[2] |
[3] |
Wikidata |
View/Edit Human |
View/Edit Mouse |
Annexin A5 (or annexin V) is a cellular protein in the annexin group. The function of the protein is unknown; however, annexin A5 has been proposed to play a role in the inhibition of blood coagulation by competing for phosphatidylserine binding sites with prothrombin and also to inhibit the activity of phospholipase A1. These properties have been found by in vitro experiments.
Contents
- 1 Pathology
- 2 Laboratory use
- 3 Interactions
- 4 References
- 5 Further reading
- 6 External links
Pathology
Antibodies directed against annexin A5 are found in patients with a disease called the antiphospholipid syndrome (APS), a thrombophilic disease associated with autoantibodies against phospholipid compounds.
Annexin A5 forms a shield around negatively charged phospholipid molecules. The formation of an annexin A5 shield blocks the entry of phospholipids into coagulation (clotting) reactions. In the antiphospholipid antibody syndrome, the formation of the shield is disrupted by antibodies. Without the shield, there is an increased quantity of phospholipid molecules on cell membranes, speeding up coagulation reactions and causing the blood-clotting characteristic of the antiphospholipid antibody syndrome.
Annexin A5 showed upregulation in papillary thyroid carcinoma.[4]
Laboratory use
Annexin A5 is used as a non-quantitative probe to detect cells that have expressed phosphatidylserine (PS) on the cell surface, an event found in apoptosis as well as other forms of cell death.[5][6][7] Platelets also expose PS and PE on their surface when activated, which serves as binding site for various coagulation factors.
The annexin A5 affinity assay typically uses a conjugate of annexin V and a fluorescent or enzymatic label, biotin or other tags, or a radioelement, in a suitable buffer (annexin V binding to aminophospholipids is Ca2+ dependent). The assay combines annexin V staining of PS and PE membrane events with the staining of DNA in the cell nucleus with propidium iodide (PI) or 7-Aminoactinomycin D (AAD-7), distinguishing viable cells from apoptotic cells and necrotic cells.[8] Detection occurs by flow cytometry or a fluorescence microscope.
Interactions
Annexin A5 has been shown to interact with Kinase insert domain receptor[9] and Integrin, beta 5.[10]
References
- ^ "chibi.ubc.ca/Gemma/phenotypes.html?phenotypeUrlId=DOID_3083&geneId=7245".
- ^ "Human PubMed Reference:".
- ^ "Mouse PubMed Reference:".
- ^ Sofiadis A, Becker S, Hellman U, Hultin-Rosenberg L, Dinets A, Hulchiy M, Zedenius J, Wallin G, Foukakis T, Höög A, Auer G, Lehtiö J, Larsson C (Apr 2012). "Proteomic profiling of follicular and papillary thyroid tumors". European Journal of Endocrinology / European Federation of Endocrine Societies. 166 (4): 657–67. doi:10.1530/EJE-11-0856. PMID 22275472.
- ^ Meers P and Mealy T (1994). "Phospholipid determinants for annexin V binding sites and the role of tryptophan". Biochemistry. 33 (19): 5829–37. doi:10.1021/bi00185a022.
- ^ Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH (Sep 1994). "Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis". Blood. 84 (5): 1415–20. PMID 8068938.
- ^ Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (Jul 1995). "A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V". Journal of Immunological Methods. 184 (1): 39–51. doi:10.1016/0022-1759(95)00072-I. PMID 7622868.
- ^ Annexin-FP488 fluorescent staining protocol at Interchim
- ^ Wen Y, Edelman JL, Kang T, Sachs G (May 1999). "Lipocortin V may function as a signaling protein for vascular endothelial growth factor receptor-2/Flk-1". Biochemical and Biophysical Research Communications. 258 (3): 713–21. doi:10.1006/bbrc.1999.0678. PMID 10329451.
- ^ Cardó-Vila M, Arap W, Pasqualini R (May 2003). "Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V". Molecular Cell. 11 (5): 1151–62. doi:10.1016/S1097-2765(03)00138-2. PMID 12769841.
Further reading
- Cederholm A, Frostegård J (Jun 2007). "Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population". Annals of the New York Academy of Sciences. 1108 (1): 96–103. doi:10.1196/annals.1422.011. PMID 17893975.
- Schlaepfer DD, Jones J, Haigler HT (Feb 1992). "Inhibition of protein kinase C by annexin V". Biochemistry. 31 (6): 1886–91. doi:10.1021/bi00121a043. PMID 1310621.
- Huber R, Berendes R, Burger A, Schneider M, Karshikov A, Luecke H, Römisch J, Paques E (Feb 1992). "Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins". Journal of Molecular Biology. 223 (3): 683–704. doi:10.1016/0022-2836(92)90984-R. PMID 1311770.
- Kirsch T, Pfäffle M (Sep 1992). "Selective binding of anchorin CII (annexin V) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). Implications for anchoring function between matrix vesicles and matrix proteins". FEBS Letters. 310 (2): 143–7. doi:10.1016/0014-5793(92)81316-E. PMID 1397263.
- Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of Infection. 24 (3): 317–20. doi:10.1016/S0163-4453(05)80037-4. PMID 1602151.
- Tait JF, Frankenberry DA, Shiang R, Murray JC, Adler DA, Disteche CM (1992). "Chromosomal localization of the human gene for annexin V (placental anticoagulant protein I) to 4q26----q28". Cytogenetics and Cell Genetics. 57 (4): 187–92. doi:10.1159/000133143. PMID 1683830.
- Huber R, Römisch J, Paques EP (Dec 1990). "The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes". The EMBO Journal. 9 (12): 3867–74. PMC 552154. PMID 2147412.
- Huber R, Schneider M, Mayr I, Römisch J, Paques EP (Nov 1990). "The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution. Implications for membrane binding and calcium channel activity". FEBS Letters. 275 (1-2): 15–21. doi:10.1016/0014-5793(90)81428-Q. PMID 2148156.
- Maurer-Fogy I, Reutelingsperger CP, Pieters J, Bodo G, Stratowa C, Hauptmann R (Jul 1988). "Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+-dependent phospholipid-binding protein". European Journal of Biochemistry / FEBS. 174 (4): 585–92. doi:10.1111/j.1432-1033.1988.tb14139.x. PMID 2455636.
- Rothhut B, Coméra C, Cortial S, Haumont PY, Diep Le KH, Cavadore JC, Conard J, Russo-Marie F, Lederer F (Nov 1989). "A 32 kDa lipocortin from human mononuclear cells appears to be identical with the placental inhibitor of blood coagulation". The Biochemical Journal. 263 (3): 929–35. doi:10.1042/bj2630929. PMC 1133519. PMID 2532007.
- Schlaepfer DD, Mehlman T, Burgess WH, Haigler HT (Sep 1987). "Structural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein". Proceedings of the National Academy of Sciences of the United States of America. 84 (17): 6078–82. doi:10.1073/pnas.84.17.6078. PMC 299011. PMID 2957692.
- Funakoshi T, Heimark RL, Hendrickson LE, McMullen BA, Fujikawa K (Aug 1987). "Human placental anticoagulant protein: isolation and characterization". Biochemistry. 26 (17): 5572–8. doi:10.1021/bi00391a053. PMID 2960376.
- Iwasaki A, Suda M, Nakao H, Nagoya T, Saino Y, Arai K, Mizoguchi T, Sato F, Yoshizaki H, Hirata M (Nov 1987). "Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein". Journal of Biochemistry. 102 (5): 1261–73. PMID 2963810.
- Funakoshi T, Hendrickson LE, McMullen BA, Fujikawa K (Dec 1987). "Primary structure of human placental anticoagulant protein". Biochemistry. 26 (25): 8087–92. doi:10.1021/bi00399a011. PMID 2964863.
- Kaplan R, Jaye M, Burgess WH, Schlaepfer DD, Haigler HT (Jun 1988). "Cloning and expression of cDNA for human endonexin II, a Ca2+ and phospholipid binding protein". The Journal of Biological Chemistry. 263 (17): 8037–43. PMID 2967291.
- Grundmann U, Abel KJ, Bohn H, Löbermann H, Lottspeich F, Küpper H (Jun 1988). "Characterization of cDNA encoding human placental anticoagulant protein (PP4): homology with the lipocortin family". Proceedings of the National Academy of Sciences of the United States of America. 85 (11): 3708–12. doi:10.1073/pnas.85.11.3708. PMC 280287. PMID 2967495.
- Pepinsky RB, Tizard R, Mattaliano RJ, Sinclair LK, Miller GT, Browning JL, Chow EP, Burne C, Huang KS, Pratt D (Aug 1988). "Five distinct calcium and phospholipid binding proteins share homology with lipocortin I". The Journal of Biological Chemistry. 263 (22): 10799–811. PMID 2968983.
- Ahn NG, Teller DC, Bienkowski MJ, McMullen BA, Lipkin EW, de Haën C (Dec 1988). "Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor". The Journal of Biological Chemistry. 263 (35): 18657–63. PMID 2974032.
- Demange P, Voges D, Benz J, Liemann S, Göttig P, Berendes R, Burger A, Huber R (Jul 1994). "Annexin V: the key to understanding ion selectivity and voltage regulation?". Trends in Biochemical Sciences. 19 (7): 272–6. doi:10.1016/0968-0004(94)90002-7. PMID 7519374.
- Fernández MP, Morgan RO, Fernández MR, Carcedo MT (Nov 1994). "The gene encoding human annexin V has a TATA-less promoter with a high G+C content". Gene. 149 (2): 253–60. doi:10.1016/0378-1119(94)90157-0. PMID 7958998.
External links
- Annexin A5 at the US National Library of Medicine Medical Subject Headings (MeSH)
PDB gallery
|
|
|
1a8a: RAT ANNEXIN V COMPLEXED WITH GLYCEROPHOSPHOSERINE
|
|
1a8b: RAT ANNEXIN V COMPLEXED WITH GLYCEROPHOSPHOETHANOLAMINE
|
|
1anw: THE EFFECT OF METAL BINDING ON THE STRUCTURE OF ANNEXIN V AND IMPLICATIONS FOR MEMBRANE BINDING
|
|
1anx: THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V
|
|
1avh: CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN ANNEXIN V AFTER REFINEMENT. IMPLICATIONS FOR STRUCTURE, MEMBRANE BINDING AND ION CHANNEL FORMATION OF THE ANNEXIN FAMILY OF PROTEINS
|
|
1avr: CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN ANNEXIN V AFTER REFINEMENT. IMPLICATIONS FOR STRUCTURE, MEMBRANE BINDING AND ION CHANNEL FORMATION OF THE ANNEXIN FAMILY OF PROTEINS
|
|
1bc0: RECOMBINANT RAT ANNEXIN V, W185A MUTANT
|
|
1bc1: RECOMBINANT RAT ANNEXIN V, QUADRUPLE MUTANT (T72K, S144K, S228K, S303K)
|
|
1bc3: RECOMBINANT RAT ANNEXIN V, TRIPLE MUTANT (T72K, S144K, S228K)
|
|
1bcw: RECOMBINANT RAT ANNEXIN V, T72A MUTANT
|
|
1bcy: RECOMBINANT RAT ANNEXIN V, T72K MUTANT
|
|
1bcz: RECOMBINANT RAT ANNEXIN V, T72S MUTANT
|
|
1g5n: ANNEXIN V COMPLEX WITH HEPARIN OLIGOSACCHARIDES
|
|
1hak: CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLACENTAL ANNEXIN V COMPLEXED WITH K-201 AS A CALCIUM CHANNEL ACTIVITY INHIBITOR
|
|
1hvd: STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
|
|
1hve: STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
|
|
1hvf: STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
|
|
1hvg: STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
|
|
1n41: Crystal Structure of Annexin V K27E Mutant
|
|
1n42: Crystal Structure of Annexin V R149E Mutant
|
|
1n44: Crystal Structure of Annexin V R23E Mutant
|
|
1sav: HUMAN ANNEXIN V WITH PROLINE SUBSTITUTION BY THIOPROLINE
|
|
2ie6: Annexin V under 2.0 MPa pressure of xenon
|
|
2ie7: Annexin V under 2.0 MPa pressure of nitrous oxide
|
|
2ran: RAT ANNEXIN V CRYSTAL STRUCTURE: CA2+-INDUCED CONFORMATIONAL CHANGES
|
|
|
Cell signaling: calcium signaling and calcium metabolism
|
|
Cell membrane |
Ion pumps
|
- SERCA
- Sodium-calcium exchanger
|
|
Cell membrane calcium channels
|
- VDCC
- TRP
- NMDA receptor
- AMPA receptor
- 5-HT3 receptor
- P2X purinoreceptor
|
|
Adhesion molecules
|
|
|
Other
|
|
|
|
Intracellular signaling
& calc. regulation |
Second messengers
|
|
|
Store gates
(ligand-gated calcium channel)
|
|
|
Molecular switches, and kinases
|
- Troponin C
- Calmodulin
- CaM kinases
- PKC
- NCS
|
|
Chelators and calcium sensors
|
- Calbindin
- S100
- pervalbumin
- Calretinin
- Calsequestrin
- Sarcalumenin
- Phospholamban
- Synaptotagmins
|
|
Proteases
|
|
|
Cytoskeleton remodeling proteins
|
|
|
Chaperones
|
|
|
Other
|
|
|
|
Calcium-binding
protein domains |
|
|
Extracellular ligands |
- Parathyroid hormone
- Calcitonin
|
|
Calcium-binding proteins |
Intracellular calcium-sensing proteins
|
- Calmodulin
- Calnexin
- Calreticulin
- Gelsolin
- neuronal
- Hippocalcin
- Neurocalcin
- Recoverin
|
|
Membrane protein
|
- Vitamin D-dependent calcium-binding protein/Calbindin
- Calexcitin
- Calsequestrin
- Osteocalcin
- Osteonectin
- S-100
- Synaptotagmin
|
|
Cytoskeleton
|
|
|
Extracellular matrix
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Role of Penaeus monodon hemocyte homeostasis associated protein (PmHHAP) in regulation of caspase-mediated apoptosis.
- Apitanyasai K1, Amparyup P2, Charoensapsri W3, Senapin S3, Tassanakajon A4.
- Developmental and comparative immunology.Dev Comp Immunol.2015 Nov;53(1):234-43. doi: 10.1016/j.dci.2015.06.004. Epub 2015 Jun 23.
- The viral responsive protein, PmHHAP, plays an important role in the control of hemocyte homeostasis in shrimps during viral infection. In this study, we further investigate the role of PmHHAP in the regulation of hemocyte apoptosis. RNA interference (RNAi) mediated gene silencing was used to suppre
- PMID 26111999
- Xanthan gum protects rabbit articular chondrocytes against sodium nitroprusside-induced apoptosis in vitro.
- Chen Q1, Mei X2, Han G3, Ling P4, Guo B2, Guo Y5, Shao H4, Wang G1, Cui Z2, Bai Y1, Xu F1.
- Carbohydrate polymers.Carbohydr Polym.2015 Oct 20;131:363-9. doi: 10.1016/j.carbpol.2015.06.004. Epub 2015 Jun 8.
- We have previously reported that intra-articular injection of xanthan gum (XG) could significantly ameliorate the degree of joint cartilage degradation and pain in experimental osteoarthritis (OA) model in vivo. In this present study, we evaluated the protective effect of XG against Sodium nitroprus
- PMID 26256195
- Inherited and acquired thrombophilia in Indian women experiencing unexplained recurrent pregnancy loss.
- Patil R1, Ghosh K1, Vora S1, Shetty S2.
- Blood cells, molecules & diseases.Blood Cells Mol Dis.2015 Oct;55(3):200-5. doi: 10.1016/j.bcmd.2015.06.008. Epub 2015 Jun 23.
- The most frequently hypothesized cause of unexplained recurrent pregnancy loss (RPL) refers to a defective maternal haemostatic response leading to uteroplacental thrombosis. Approximately 20% women suffering from pregnancy loss (PL) are associated with autoimmune disorders and more than 50% remain
- PMID 26227844
Japanese Journal
- 高速原子間力顕微鏡による生体試料のダイナミクス観察 (特集 境界領域シンポジウム「膜解析の最前線 : 生体膜・膜タンパク質から模擬膜,ソフトマターまで)
- Suppressive Effects of Irbesartan on Inflammation and Apoptosis in Atherosclerotic Plaques of apoE(-/-) Mice: Molecular Imaging with C-14-FDG and Tc-99m-Annexin A5
- Zhao Yan,Watanabe Ayahisa,Zhao Songji,Kobayashi Tatsuo,Fukao Keita,Tanaka Yoshikazu,Nakano Toru,Yoshida Tetsuya,Takemoto Hiroshi,Tamaki Nagara,Kuge Yuji
- Plos one 9(2), e89338, 2014-02-19
- … Objectives: To investigate the effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques by histochemical examination and molecular imaging using C-14-FDG and Tc-99m-annexin A5. … Molecular imaging using F-18-FDG and Tc-99m-annexin A5 is useful for evaluating inflammation and apoptosis in atherosclerotic plaques. … One week after the treatment, the mice were co-injected with C-14-FDG and Tc-99m-annexin A5, and cryostat sections of the aortic root were prepared. …
- NAID 120005427743
- P1-15-7 Annexin A4の発現は細胞内クロールイオン濃度を上昇させ,プラチナ耐性を誘導する(Group 15 卵巣腫瘍・基礎2,一般演題,公益社団法人日本産科婦人科学会第66回学術講演会)
- 森本 晶子,松崎 慎哉,高田 友美,小林 栄仁,木村 敏啓,上田 豊,吉野 潔,藤田 征巳,榎本 隆之,仲 哲治,木村 正
- 日本産科婦人科學會雜誌 66(2), 511, 2014-02-01
- NAID 110009811754
Related Links
- Annexin Vはアポトーシスにより膜表面に露出したPSに結合します。これによりアポトーシス細胞を検出することできます。 FITC標識したAnnexin VとPIを利用することによって、早期のアポトーシスと後期のアポトーシスを区別することも可能 ...
- メーカー 商品コード 商品名 包装 価格 在庫 リスト BVN バイオビジョン BioVision, Inc. データシート K201-25 Annexin V-FITC Apoptosis Detection Kit Plus (25 assays) 1kit \30,000 1個 済 追加 BVN バイオビジョン BioVision, Inc. データシート
Related Pictures
★リンクテーブル★
[★]
- 英
- annexin V
- 関
- 胎盤抗凝固タンパク質I、アネキシンA5
[★]
- 関
- annexin A5、annexin V
[★]
アネキシンVII
- 関
- annexin A7、synexin
[★]
アネキシンVI
- 関
- annexin A6
[★]
[★]
[★]
- 関
- adduct
[★]
アネキシン
- 関
- calpactin、lipocortin